PMC Links for GEO Profiles (Select 130567394) - PMC

Links from GEO Profiles

Items: 1 to 20 of 253

<< First< Prev

Page of 13

Select item 112930801.

KIR2DL1 gene is a surrogate marker of protection against infection-related hospitalization among HIV-1 unexposed versus exposed uninfected infants in Cameroon

Luc-Aimé Kagoué Simeni, Gabriel Loni Ekali, Clauvis Kunkeng Yengo, Rodrigue Kamga Wouambo, Janett Fischer, Oumarou M’rikam A. Bessong, Joseph Fokam, Louis-Marie Yindom, Jules Clément Assob Nguedia

BMC Immunol. 2024; 25: 54. Published online 2024 Aug 1. doi: 10.1186/s12865-024-00645-9

PMCID:: PMC11293080

Abstract Article PDF–1.5M

Select item 110327722.

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals

Elissaveta Naumova, Anastassia Mihaylova, Konstantin Stoitchkov, Milena Ivanova, Ludmila Quin, Miglena Toneva

Cancer Immunol Immunother. 2005 Feb; 54(2): 172–178. Published online 2004 Jul 10. doi: 10.1007/s00262-004-0575-z

PMCID:: PMC11032772

Abstract Article PDF–208K

Select item 106515403.

The KIR2DL1 intermediate upstream element participates in gene activation

Paul W. Wright, Hongchuan Li, Md Ahasanur Rahman, Erik M. Anderson, Megan Karwan, Jeffrey Carrell, Stephen K. Anderson

Immunogenetics. 2023; 75(6): 495–506. Published online 2023 Oct 6. doi: 10.1007/s00251-023-01321-9

PMCID:: PMC10651540

Abstract Article PDF–3.7M

Select item 104680494.

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma

Beatrice M. Muriuki, Catherine S. Forconi, Erastus K. Kirwa, Titus K. Maina, Bonface O. Ariera, Jeffrey A. Bailey, Anita Ghansah, Ann M. Moormann, John M. Ong’echa

PLoS One. 2023; 18(8): e0275046. Published online 2023 Aug 30. doi: 10.1371/journal.pone.0275046

PMCID:: PMC10468049

Abstract Article PDF–938K

Select item 103604435.

Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells

William H. Palmer, Laura Ann Leaton, Ana Campos Codo, Bergren Crute, James Roest, Shiying Zhu, Jan Petersen, Richard P. Tobin, Patrick S. Hume, Matthew Stone, Adrie van Bokhoven, Mark E. Gerich, Martin D. McCarter, Yuwen Zhu, William J. Janssen, Julian P. Vivian, John Trowsdale, Andrew Getahun, Jamie Rossjohn, John Cambier, Liyen Loh, Paul J. Norman

Sci Immunol. Author manuscript; available in PMC 2024 Jun 30.

Published in final edited form as: Sci Immunol. 2023 Jun 30; 8(84): eade5343. Published online 2023 Jun 30. doi: 10.1126/sciimmunol.ade5343

PMCID:: PMC10360443

Abstract Article PDF–2.9M

Select item 103298616.

KIR Allelic Variation and the Remission of Atopic Dermatitis Over Time

David J. Margolis, Nandita Mitra, Ole J. Hoffstad, Abha Chopra, Elizabeth J. Phillips

Immunohorizons. 2023 Jan 1; 7(1): 30–40. Published online 2023 Jan 13. doi: 10.4049/immunohorizons.2200095

PMCID:: PMC10329861

Abstract Article PDF–845K

Select item 103201967.

Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia

Falk Heidenreich, Bose Falk, Henning Baldauf, Carolin Massalski, Gesine Schäfer, Elke Rücker-Braun, Heidi Altmann, Jürgen Sauter, Ute V. Solloch, Vinzenz Lange, Friedrich Stölzel, Christoph Röllig, Jan M. Middeke, Malte von Bonin, Christian Thiede, Kerstin Schäfer-Eckart, Carsten Müller-Tidow, Stefan W. Krause, Sabrina Kraus, Martin Kaufmann, Mathias Hänel, Hubert Serve, Andreas Neubauer, Martin Bornhäuser, Alexander H. Schmidt, Johannes Schetelig

Blood Adv. 2023 Jul 11; 7(13): 2994–3004. Published online 2023 Jan 26. doi: 10.1182/bloodadvances.2022008514

PMCID:: PMC10320196

Abstract Article PDF–489K

Select item 101731908.

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy

Yang Li, Chao Lv, Yang Yu, Baokang Wu, Yizhou Zhang, Qi Lang, Zhiyun Liang, Chongli Zhong, Yu Shi, Shukun Han, Feng Xu, Yu Tian

J Adv Res. 2023 May; 47: 137–150. Published online 2022 Aug 4. doi: 10.1016/j.jare.2022.07.013

PMCID:: PMC10173190

Abstract Article PDF–1.6M

Select item 100387579.

Immunogenomics of killer cell Ig-like receptor (KIR) and HLA class I: Co-evolution and consequences for human health

Nicholas R. Pollock, Genelle F. Harrison, Paul J. Norman

J Allergy Clin Immunol Pract. Author manuscript; available in PMC 2023 Mar 25.

Published in final edited form as: J Allergy Clin Immunol Pract. 2022 Jul; 10(7): 1763–1775. Published online 2022 May 10. doi: 10.1016/j.jaip.2022.04.036

PMCID:: PMC10038757

Abstract Article PDF–842K

Select item 1001356810.

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19

Ruihua Wang, Ying Sun, Bo-Hua Kuang, Xiao Yan, Jinju Lei, Yu-Xin Lin, Jinxiu Tian, Yating Li, Xiaoduo Xie, Tao Chen, Hui Zhang, Yi-Xin Zeng, Jincun Zhao, Lin Feng

Emerg Microbes Infect. 2023; 12(1): 2185467. Published online 2023 Mar 13. doi: 10.1080/22221751.2023.2185467

PMCID:: PMC10013568

Abstract Article PDF–5.0M

Select item 988938011.

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis

David J. Margolis, Nandita Mitra, Ole J. Hoffstad, Ronald Berna, Brian S. Kim, Abha Chopra, Elizabeth J. Phillips

Sci Rep. 2023; 13: 1730. Published online 2023 Jan 31. doi: 10.1038/s41598-023-28847-y

PMCID:: PMC9889380

Abstract Article PDF–969K

Select item 988042812.

Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure

Ee Von Woon, Dimitrios Nikolaou, Kate MacLaran, Julian Norman-Taylor, Priya Bhagwat, Antonia O. Cuff, Mark R. Johnson, Victoria Male

Front Immunol. 2022; 13: 1108163. Published online 2023 Jan 13. doi: 10.3389/fimmu.2022.1108163

PMCID:: PMC9880428

Abstract Article PDF–2.2M

Select item 984175713.

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients

Gülay Sezgin, Özlem Görüroğlu Öztürk, Ayşe Özkan, Serhan Küpeli, İbrahim Bayram

Med Princ Pract. 2023 Jan; 31(6): 532–539. Published online 2022 May 10. doi: 10.1159/000524656

PMCID:: PMC9841757

Abstract Article PDF–383K

Select item 978132314.

Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells

Zening Yang, Jing Li, Jiali Li, Huiwen Zheng, Heng Li, Qingrun Lai, Yanli Chen, Li Qin, Yuanyuan Zuo, Lei Guo, Haijing Shi, Longding Liu

Vaccines (Basel) 2022 Dec; 10(12): 2042. Published online 2022 Nov 29. doi: 10.3390/vaccines10122042

PMCID:: PMC9781323

Abstract Article PDF–22M

Select item 974457815.

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

Yao Wei, Xiaoxin Ren, Phillip M. Galbo, Jr, Scott Moerdler, Hao Wang, R. Alejandro Sica, Bijan Etemad-Gilbertson, Lei Shi, Liqiang Zhu, Xudong Tang, Qi Lin, Mou Peng, Fangxia Guan, Deyou Zheng, Jordan M. Chinai, Xingxing Zang

Sci Immunol. Author manuscript; available in PMC 2022 Dec 12.

Published in final edited form as: Sci Immunol. 2021 Jul 9; 6(61): eabf9792. doi: 10.1126/sciimmunol.abf9792

PMCID:: PMC9744578

Abstract Article PDF–3.2M

Select item 957870716.

Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform

Dirk H Siepe, Lukas T Henneberg, Steven C Wilson, Gaelen T Hess, Michael C Bassik, Kai Zinn, K Christopher Garcia

eLife. 2022; 11: e81398. Published online 2022 Sep 30. doi: 10.7554/eLife.81398

PMCID:: PMC9578707

Abstract Article PDF–3.3M

Select item 930146417.

The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection

Song Hu, Zuoyu Shao, Wei Ni, Pan Sun, Jialu Qiao, Hexing Wan, Yi Huang, Xiaolong Liu, Haoyang Zhai, Mingzhong Xiao, Binlian Sun

Front Immunol. 2022; 13: 919110. Published online 2022 Jul 7. doi: 10.3389/fimmu.2022.919110

PMCID:: PMC9301464

Abstract Article PDF–640K

Select item 894147718.

CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome

Inès Vergnolle, Claudia Douat-Beyries, Serge Boulinguez, Jean-Baptiste Rieu, Jean-Philippe Vial, Rolande Baracou, Sylvie Boudot, Aurore Cazeneuve, Sophie Chaugne, Martine Durand, Sylvie Estival, Nicolas Lablanche, Marie-Laure Nicolau-Travers, Emilie Tournier, Laurence Lamant, François Vergez

Blood Adv. 2022 Mar 22; 6(6): 1813–1825. Published online 2022 Mar 16. doi: 10.1182/bloodadvances.2021005147

PMCID:: PMC8941477

Abstract Article PDF–1.9M

Select item 889673319.

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1

Genelle F. Harrison, Laura Ann Leaton, Erica A. Harrison, Katherine M. Kichula, Marte K. Viken, Jonathan Shortt, Christopher R. Gignoux, Benedicte A. Lie, Damjan Vukcevic, Stephen Leslie, Paul J. Norman

PLoS Comput Biol. 2022 Feb; 18(2): e1009059. Published online 2022 Feb 22. doi: 10.1371/journal.pcbi.1009059

PMCID:: PMC8896733

Abstract Article PDF–1.9M

Select item 882890620.

Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma

Peijia Jiang, Ilja M. Nolte, Bouke G. Hepkema, Marijke Stulp, Anke van den Berg, Arjan Diepstra

Front Immunol. 2022; 13: 829943. Published online 2022 Jan 27. doi: 10.3389/fimmu.2022.829943

PMCID:: PMC8828906

Abstract Article PDF–1.9M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from GEO Profiles

Items: 1 to 20 of 253

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity